Changbin Zhu

机构：Dian Diagnostics (China)

发表论文 89 篇 · 总被引 1099 次 · h-index 18

代表论文

• Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer (2025 · Cancer Cell · 被引 75)
• Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial (2024 · EClinicalMedicine · 被引 37)
• Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial (2024 · Signal Transduction and Targeted Therapy · 被引 30)
• Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population (2024 · Pathology - Research and Practice · 被引 25)
• Association between homologous recombination deficiency status and carboplatin treatment response in early triple-negative breast cancer (2024 · Breast Cancer Research and Treatment · 被引 14)
• Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma (2024 · npj Precision Oncology · 被引 14)